Matthew R Patterson - Net Worth and Insider Trading
Matthew R Patterson Net Worth
The estimated net worth of Matthew R Patterson is at least $17 Million dollars as of 2024-11-10. Matthew R Patterson is the CEO of Audentes Therapeutics Inc and owns about 285,208 shares of Audentes Therapeutics Inc (BOLD) stock worth over $17 Million. Details can be seen in Matthew R Patterson's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Matthew R Patterson has not made any transactions after 2019-11-08 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Matthew R Patterson
Matthew R Patterson Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Matthew R Patterson owns 5 companies in total, including 5:01 Acquisition Corp (FVAM) , Homology Medicines Inc (FIXX) , and Audentes Therapeutics Inc (BOLD) among others .
Click here to see the complete history of Matthew R Patterson’s form 4 insider trades.
Insider Ownership Summary of Matthew R Patterson
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| FVAM | 5:01 Acquisition Corp | 2020-10-13 | director |
| FIXX | Homology Medicines Inc | 2018-03-27 | director |
| BOLD | Audentes Therapeutics Inc | 2020-01-15 | director & Chief Executive Officer |
 | | 2007-05-30 | Chief Operating Officer |
| | 2021-02-04 | director |
Matthew R Patterson Latest Holdings Summary
Matthew R Patterson currently owns a total of 1 stock. Matthew R Patterson owns 285,208 shares of Audentes Therapeutics Inc (BOLD) as of November 8, 2019, with a value of $17 Million.
Latest Holdings of Matthew R Patterson
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BOLD | Audentes Therapeutics Inc | 2019-11-08 | 285,208 | 59.97 | 17,103,924 |
Holding Weightings of Matthew R Patterson
Matthew R Patterson Form 4 Trading Tracker
According to the SEC Form 4 filings, Matthew R Patterson has made a total of 0 transactions in Audentes Therapeutics Inc (BOLD) over the past 5 years. The most-recent trade in Audentes Therapeutics Inc is the sale of 14,426 shares on November 8, 2019, which brought Matthew R Patterson around $432,780.
Insider Trading History of Matthew R Patterson
- 1
Matthew R Patterson Trading Performance
Matthew R Patterson Ownership Network
Ownership Network List of Matthew R Patterson
Ownership Network Relation of Matthew R Patterson
Matthew R Patterson Owned Company Details
What does 5:01 Acquisition Corp do?
Who are the key executives at 5:01 Acquisition Corp?
Matthew R Patterson is the director of 5:01 Acquisition Corp. Other key executives at 5:01 Acquisition Corp include director & 10 percent owner & Co-CEO Andrew J. Schwab , director & 10 percent owner & Co-CEO Kush Parmar , and 10 percent owner 5am Ventures Vi, L.p. .
5:01 Acquisition Corp (FVAM) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of 5:01 Acquisition Corp (FVAM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of 5:01 Acquisition Corp (FVAM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
5:01 Acquisition Corp (FVAM)'s detailed insider trading history can be found in Insider Trading Tracker table.
5:01 Acquisition Corp Insider Transactions
Matthew R Patterson Mailing Address
Above is the net worth, insider trading, and ownership report for Matthew R Patterson. You might contact Matthew R Patterson via mailing address: C/o Amicus Therapeutics, Inc., 6 Cedar Brook Drive, Cranbury Nj 08512.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
